A Single-center, Randomized, Open-label, Crossover Study to Assess the Relative Bioavailability of New Formulations of GSK1265744 in Healthy Adult Subjects
Phase of Trial: Phase I
Latest Information Update: 19 Aug 2016
At a glance
- Drugs Cabotegravir (Primary)
- Indications Hepatitis; HIV-1 infections
- Focus Pharmacokinetics
- 01 Nov 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 05 Oct 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 01 Aug 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.